Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print RBP4 predicts type 2 diabetes
Slashdot It! Slashdot RBP4 predicts type 2 diabetes
Submit to Reddit Submit RBP4 predicts type 2 diabetes to Reddit
Reading: RBP4 predicts type 2 diabetesTwitter This Reading: RBP4 predicts type 2 diabetesTwitter RBP4 predicts type 2 diabetes
Add to Facebook Add RBP4 predicts type 2 diabetes to Facebook

RBP4 predicts type 2 diabetes

June 15, 2006

Elevation of fat-derived molecule foretells early insulin resistance
BOSTON — A study in the June 15 issue of The New England Journal of Medicine (NEJM) reveals that elevated levels of a molecule called RBP4 (retinol binding protein 4) can foretell early stages in the development of insulin resistance, a major cause of type 2 diabetes as well as cardiovascular disease.

The new findings, led by researchers at Beth Israel Deaconess Medical Center (BIDMC), offer a potential new target for the development of anti-diabetic therapies to lower serum RBP4 levels as well as an early means of identifying individuals who are at risk of developing diabetes — before the onset of overt disease.




"Type 2 diabetes is a rapidly increasing epidemic in the Western world," explains senior author Barbara Kahn, MD, Chief of the Division of Diabetes, Endocrinology and Metabolism at BIDMC and Professor of Medicine at Harvard Medical School. "Since it is now occurring even in childhood, predictions indicate that it could shorten lifespan in the U.S. for the first time in more than a century."

Insulin resistance develops when the body's muscles, fat and liver cells lose the ability to respond to the hormone insulin. Because insulin is necessary to enable the body to take up sugar from blood and convert it into energy, this impairment results in a buildup of glucose in the bloodstream.

"Insulin resistance not only predisposes individuals to type 2 diabetes, it is also a major risk factor for cardiovascular disease," adds co-lead author Timothy Graham, MD, an investigator in the Kahn laboratory. "Unfortunately, in the clinical setting, it is often difficult to distinguish individuals with and without insulin resistance."

Last year, in a study conducted in animals, Kahn's laboratory made the discovery that RBP4, a protein secreted from fat, can cause insulin resistance. Prior to this, the molecule was recognized only for its role in the transport of vitamin A.

In this new research, Graham, together with co-lead author Qin Yang, MD, PhD, set out to determine whether levels of RBP4, as measured in blood, correlate with the presence or absence of insulin resistance. (Study subjects represented three separate cohorts from San Diego, California; Goteberg, Sweden; and Leipzig, Germany.)

They first studied individuals with either obesity, impaired glucose tolerance (a "pre-diabetic" state), or with type 2 diabetes, comparing the blood levels of RBP4 in these insulin-resistant subjects with levels found in non-obese healthy subjects. Their results showed that not only were RBP4 levels higher in all cases in which insulin resistance was high, but that elevated serum RBP4 was also closely associated with components of the metabolic syndrome, including increased body mass index, waist-to-hip ratio, serum triglyceride levels, and systolic blood pressure, as well as decreased levels of high-density lipoprotein (HDL), or good, cholesterol.

The study was then extended to subjects with normal body weight and normal blood glucose, but with a strong family history of type 2 diabetes. "These are people who appear healthy, but have a high risk of developing diabetes due to their genetic background," explains Ulf Smith, MD, PhD, of Sahlgrenska Hospital, Goteberg, Sweden, where this group of subjects was based. As predicted, the investigators found elevated RBP4 levels among this group as well.

Finally, the authors tested whether a therapeutic intervention — in this case, exercise — could lower RBP4 levels and increase insulin sensitivity. They found that all of the people who improved their insulin sensitivity with exercise also lowered their serum RBP4 levels. Among the one-third of the subjects who did not improve their insulin sensitivity, neither did RBP4 levels go down.

"Collectively, these findings tell us that RBP4 is a useful marker for therapeutic improvement and that this protein could play a causal role in insulin resistance in humans, just as our lab previously showed in mice," says Kahn. Furthermore, she adds, because RBP4 levels consistently corresponded with insulin resistance — even among lean subjects whose genetic risk for the development of diabetes might otherwise be overlooked — this protein could be an important marker for type 2 diabetes among the general population.

"Being able to determine diabetes risk well before the onset of symptoms could provide an important opportunity for patients to take preventive measures," she adds. "For those who are overweight or sedentary, this could mean making changes to their diet and fitness routines. For those who are lean and fit, but have a family history of type 2 diabetes, this could mean taking antidiabetic medication. Either way, these findings could help clinicians to better manage this growing epidemic."

Beth Israel Deaconess Medical Center





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Cancer Diagnosis   Smallpox   Omega-3 Fatty Acids   Volcanic Activity   Pancreatic Cancer   Pre-eclampsia   Sarcoma   Prenatal alcohol exposure   Antibiotic Resistance   Cognitive Decline   Smoking cessation   Endangered Species   Rice   Stem cells   Ferroelectric   Kidney Failure   Sickle Cell   Seizures   Stem Cell Transplant   HPV   Aging   Tanning   Heart Transplant   life on Mars   Cord Blood  
Related Type 2 Diabetes Current Events and Type 2 Diabetes News Articles Type 2 Diabetes Current Events and Type 2 Diabetes News RSS Type 2 Diabetes Current Events and Type 2 Diabetes News RSS
ADA releases updated position paper on vegetarian diets
The American Dietetic Association has released an updated position paper on vegetarian diets that concludes such diets, if well-planned, are healthful and nutritious for adults, infants, children and adolescents and can help prevent and treat chronic diseases including heart disease, cancer, obesity and diabetes.

Glucose challenge test is accurate and economical for diabetes and prediabetes screening
A test commonly used to help identify women with diabetes during pregnancy may be an accurate, convenient and inexpensive way to screen the general population for unrecognized diabetes and prediabetes, according to Emory University researchers.

Patients with lower urinary tract symptoms more likely to suffer from metabolic syndrome
Researchers have determined that individuals with mild to severe symptoms of lower urinary tract symptoms (LUTS) are more likely to suffer from metabolic syndrome (MetS), a collection of cardiovascular risk factors thought to be linked by insulin resistance).

Benefit of glinides is not proven
The benefit of glinides in the treatment of type 2 diabetes is not scientifically proven. Nor do they perform better than other antidiabetics available in tablet form, such as metformin and sulfonylureas.

Sleep apnea occurring during REM sleep is significantly associated with type 2 diabetes
A multi-ethnic study in the June 15 issue of the Journal of Clinical Sleep Medicine reports that there is a statistically significant relationship between obstructive sleep apnea (OSA) episodes occurring during rapid eye movement (REM) sleep and type 2 diabetes.

TGen researchers find genetic markers to help fight diabetes
Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.

Screening for left ventricular dysfunction may have less value than thought
The value and cost-effectiveness of screening for left ventricular (LV) dysfunction remains unclear, particularly since specific, evidence-based treatments are not available for the majority of patients with preserved systolic dysfunction.

What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus?
Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths.

Low-fat diet helps genetically predisposed animals avoid liver cancer
In a study comparing two strains of mice, one susceptible to developing cancer and the other not, researchers found that a high-fat diet predisposed the cancer-susceptible strain to liver cancer, and that by switching to a low-fat diet early in the experiment, the same high-risk mice avoided the malignancy.

Snoring pregnant women at higher risk for gestational diabetes
If you are pregnant and your mate complains your frequent snoring is rattling the bedroom windows, you may have bigger problems than an annoyed, sleep-deprived partner.
More Type 2 Diabetes Current Events and Type 2 Diabetes News Articles
The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed (First Year, The)

The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed (First Year, The)
by Gretchen Becker (Author), Allison B. Goldfine (Foreword)

After Gretchen Becker was diagnosed with type 2 diabetes in 1996, she educated herself on every aspect of this chronic condition — by reading medical and scientific books and journals, talking with doctors and listening to her own body. In 2001, she marshaled everything she had learned as a "patient-expert" into the first edition of this book, which she has now completely updated and revised. The First Year®—Type 2 Diabetes uniquely guides you step-by-step through your first year with diabetes, walking you through everything you need to learn and do each day of your first week after diagnosis, each subsequent week of the first month, and each subsequent month of the crucial first year. In clear, concise, accessible language, Becker covers a wide range of practical, medical, and...

A Field Guide to Type 2 Diabetes

A Field Guide to Type 2 Diabetes
by American Diabetes Association (Author), Marie McCarren (Author)

The best consumer guide to type 2 diabetes. Explains in down-to-earth language the best way to live with this chronic disease that is affecting a growing number of people. Information for all the "times" with type 2 diabetes that you will experience over the years--when you are newly diagnosed; taking one, two, or three kinds of diabetes pills; or adding insulin. It explains the tools to use to prevent complications. It includes chapters on women, children and teens, and how to prevent diabetes from occuring in family members who are at high risk for it.

The Other Diabetes: Living and Eating Well with Type 2 Diabetes

The Other Diabetes: Living and Eating Well with Type 2 Diabetes
by Elizabeth N. Hiser (Author)

Our national epidemic of type 2 diabetes, obesity, and heart disease is the price we pay for a diet that is too rich for our modern lifestyle. To fight back, we have focused on eating low-fat foods and quick-fix diets that just don't seem to work. The Other Diabetes, a consumer guide to type 2 diabetes, can help you change all that with the optimal eating plan. The Good Fat Diet offers a collection of eighty healthy and wholesome recipes.



Mayo Clinic Wellness Solutions for Type 2 Diabetes

Mayo Clinic Wellness Solutions for Type 2 Diabetes
Starring: Rodney Yee, Dr. Brent A. Bauer Mayo Clinic and Dr. Lori R. Roust Mayo Clinic
Directed By: Cathe Neukum

TAKE CHARGE OF YOUR HEALTH
Mayo Clinic, one of the top medical centers in the country, and GAIAM, the health and wellness experts, team up to bring you this groundbreaking, integrated health action plan designed specifically to improve control of diabetes. Changing the way you live can change the way you feel.
PART 1: UNDERSTANDING YOUR CONDITION
A 30-minute conversation with Mayo Clinic specialists. Dr. Brent Bauer introduces you to the integrative treatment approach, and Mayo Clinic doctors share everything you need to know about diabetes and the array of conventional and alternative therapy options.
PART 2: EAT WELL TO FEEL WELL
Change your diet to feel better. Dr. Donald Hensrud, Chair, Preventive Medicine, Mayo Clinic, takes you grocery shopping and shares smart...

  Type 2 Diabetes: An Essential Guide for the Newly Diagnosed
by Marlowe & Company

After Gretchen Becker was diagnosed with type 2 diabetes in 1996, she educated herself on every aspect of this chronic condition — by reading medical and scientific books and journals, talking with doctors and listening to her own body. In 2001, she marshaled everything she had learned as a "patient-expert" into the first edition of this book, which she has now completely updated and revised. The First Year®—Type 2 Diabetes uniquely guides you step-by-step through your first year with diabetes, walking you through everything you need to learn and do each day of your first week after diagnosis, each subsequent week of the first month, and each subsequent month of the crucial first year. In clear, concise, accessible language, Becker covers a wide range of practical, medical, and...

The Complete Idiot's Guide to Type 2 Diabetes

The Complete Idiot's Guide to Type 2 Diabetes
by M.D. Mayer B. Davidson (Author), Debra L. Gordon (Author)

The most complete book on the epidemic of Type 2 Diabetes.

Over the next decade, the number of diagnosed diabetes cases worldwide is expected to exceed 220 million, 90-95% of which will be Type 2 Diabetes. Here is a guide that answers all the questions patients have: What is it? How will it affect my life? What do I need to do? It teaches readers how to manage the disease and live a healthy, normal life.

-More than 18 million Americans have diabetes

-The number of U.S. adults with diagnosed diabetes has increased 61% since 1991, and will more than double by 2050

-1 in 5 people over the age of 65 has diabetes, indicating that the disease indirectly affects many people in care-giving roles

-Diabetes is one of our health care system’s most expensive diseases, costing the...

American Medical Association Guide to Living with Diabetes: Preventing and Treating Type 2 Diabetes - Essential Information You and Your Family Need to Know

American Medical Association Guide to Living with Diabetes: Preventing and Treating Type 2 Diabetes - Essential Information You and Your Family Need to Know
by American Medical Association (Author), Boyd E. Metzger MD (Author)

More Than 3 Million American Medical Association Books Sold

From America's Most Trusted Health Authority, the Ultimate Guide to Understanding, Preventing, and Managing Type 2 Diabetes

Millions of Americans have type 2 diabetes, and millions more are at risk of developing the disease. The good news is that it is both preventable and treatable. In the American Medical Association Guide to Living with Diabetes you'll learn everything you need to know to prevent type 2 diabetes, take control of it if you already have it, and reduce your risk of life-threatening complications.

This book provides clear, easy-to-understand explanations of what type 2 diabetes is, what causes it, and how to determine if you are at risk. You'll find a detailed,...

FlameEz-Glucose, 60 Capsules/Bottle

FlameEz-Glucose, 60 Capsules/Bottle
by FlameEz

Inflammation has been considered as a key mechanism leading to type 2 diabetes. Inflammation takes place in pancreatic islets at early stage of type 2 diabetes. Inflammatory mediators promote pancreatic beta-cell dysfunction and cause the neighboring liver, muscle or fat cells to become insulin resistant. Inflammation is also accounted for vascular damage leading to diabetic complications, including cardiovascular disease, kidney dysfunction, retinopathy, and peripheral neuropathy. These complications are responsible for the vast majority of diabetes-related mortality. Medical community has already recognized that modulation of immune and inflammatory responses may have tremendous benefit to type 2 diabetes. Current recommendations to prevent type 2 diabetes center on lifestyle...

Diabetes Type 2 GUIDELINES Pocketcard: American Association of Clinical Endocrinologists (2008)

Diabetes Type 2 GUIDELINES Pocketcard: American Association of Clinical Endocrinologists (2008)
by International Guidelines Center

The Diabetes Mellitus Type 2 GUIDELINES Pocketcard provides all that is needed to make accurate clinical decisions at the point of care including: Key points; Treatment Algorithm; Glycemic Control Module; Hypertension (HTN) Management Module; Eye Care Module; Neuropathy Module; Foot Care Module; Cardiac-Peripheral Vascular Module; Renal Disease Module; Current Medication Tables with Brand and Generic Names; Detailed drug information - strengths, formulations, side effects, comments.

Diabetes Type 2 Guidelines Pocketcard : Amer Assn of Clinica

Diabetes Type 2 Guidelines Pocketcard : Amer Assn of Clinica
by International Guidelines Cntr

The Diabetes Mellitus Type 2 GUIDELINES Pocketcard is endorsed by the American Association of Clinical Endocrinologists (AACE). This practical quick-reference tool contains screening, diagnostic, treatment algorithm, drug therapy, dosing information, patient monitoring and counseling points

© 2009 BrightSurf.com